Three residents were honored for their leadership, education and research, and patient care contributions in ophthalmology, ...

Patient enrollment is complete in the the ASTRA phase 3 study AURN001 to treat corneal edema associated with corneal ...

The phase 2 ArMaDa results showed that one subretinal injection of medium-dose OCU410, an investigational adeno-associated ...

Breazzano, MD, FACS, shares findings from a TriNetX real-world database analysis on how HIV co-infection influences RPR ...

Dilsher S. Dhoot, MD, FASRS, breaks down the Phase 3 SOL-1 results on intravitreal axitinib hydrogel (OTX-TKI) and ...

Chhablani reports revakinagene taroretcel-lwey slowed cavitation volume growth and preserved photoreceptor structure in MacTel type 2.

The alternative pathway ratios Ba/Factor B (0.350, 95% CrI: 0.021 to 0.644), and Bb/Factor B (0.203, 95% CrI: -0.086 to 0.475 ...

At the Retina Society 59th Annual Scientific Meeting in Los Angeles, California, Christine Kay, MD, presented 4-year durability data for MCO-010 (Nanoscope Therapeutics). MCO-010 ...

Periocular reconstruction in children presents a different challenge from that in adults and requires a different approach to reconstructive planning to achieve success.¹ For exa ...

Rates of PDR, vitreous hemorrhage, and discontinuations due to adverse events were higher with remigromig than ranibizumab.

At ESCRS 2026, Jascha Wendelstein, MD, noted standard ETDRS visual acuity testing misses functional differences between ...

EURETINA President Nicole Eter, MD, picks the sessions busy clinicians should follow at the 26th EURETINA Congress in Vienna, from durability data to AI. She also explains why early referral is still ...